Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy
Authors:
Open Access
- 6 January 2014
- journal article
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 15 (1) , 38-46
Abstract
The purpose of this study was to investigate the impact of Monte Carlo (MC) calculations and optimized dose definitions in stereotactic body radiotherapy (SBRT) for lung cancer patients. We used a retrospective patient review and basic virtual phantom to determine dose prescriptions. Fifty-three patients underwent SBRT. A basic virtual phantom had a gross tumor volume (GTV) of 10.0 mm with equivalent water density of 1.0 g/cm3, which was surrounded by equivalent lung surrounding the GTV of 0.25 g/cm3. D95 of the planning target volume (PTV) and D99 of the GTV were evaluated with different GTV sizes (5.0 to 30.0 mm) and different lung densities (0.05 to 0.45 g/cm3). Prescribed dose was defined as 95% of the PTV should receive 100% of the dose (48 Gy/4 fractions) using pencil beam (PB) calculation and recalculated using MC calculation. In the patient study, average doses to the D95 of the PTV and D99 of the GTV using the MC calculation plan were 19.9% and 10.2% lower than those by the PB calculation plan, respectively. In the phantom study, decreased doses to the D95 of the PTV and D99 of the GTV using the MC calculation plan were accompanied with changes GTV size from 30.0 to 5.0 mm, which was decreased from 8.4% to 19.6% for the PTV and from 17.4% to 27.5% for the GTV Similar results were seen with changes in lung density from 0. 45 to 0.05 g/cm3, with doses to the D95 of the PTV and D99 of the GTV were decreased from 12.8% to 59.0% and from 7.6% to 44.8%, respectively. The decrease in dose to the PTV with MC calculation was strongly dependent on lung density. We suggest that dose definition to the GTV for lung cancer SBRT be optimized using MC calculation. Our current clinical protocol for lung SBRT is based on a prescribed dose of 44 Gy in 4 fractions to the GTV using MC calculation. PACS number: 87.55.D-, 87.55.K-Keywords
This publication has 21 references indexed in Scilit:
- Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): comparison of commercially available Monte Carlo dose calculation with other algorithmsRadiation Oncology, 2012
- Stereotactic Radiotherapy of Primary Lung Cancer and Other Targets: Results of Consultant Meeting of the International Atomic Energy AgencyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Verification measurements and clinical evaluation of the iPlan RT Monte Carlo dose algorithm for 6 MV photon energyPhysics in Medicine & Biology, 2010
- Dosimetric verification and clinical evaluation of a new commercially available Monte Carlo-based dose algorithm for application in stereotactic body radiation therapy (SBRT) treatment planningPhysics in Medicine & Biology, 2010
- Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapyMedical Physics, 2007
- Interinstitutional Variations in Planning for Stereotactic Body Radiation Therapy for Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frameInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinomaCancer, 2004
- Extracranial Stereotactic Radioablation *Chest, 2003
- A virtual photon energy fluence model for Monte Carlo dose calculationMedical Physics, 2003